Royal Bank of Canada’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Buy |
|
|||||
|
2025
Q1 | $9K | Sell |
|
|||||
|
2024
Q4 | $26K | Buy |
|
|||||
|
2024
Q3 | $24K | Buy |
|
|||||
|
2024
Q2 | $21K | Buy |
|
|||||
|
2024
Q1 | $0 | Sell |
|
|||||
|
2023
Q4 | $0 | Buy |
|
|||||
|
2023
Q3 | $0 | Sell |
|
|||||
|
2023
Q2 | $0 | Sell |
|
|||||
|
2023
Q1 | $8K | Sell |
|
|||||
|
2022
Q4 | $80K | Buy |
|
|||||
|
2022
Q3 | $50K | Buy |
|
|||||
|
2022
Q2 | $32K | Sell |
|
|||||
|
2022
Q1 | $75K | Buy |
|
|||||
|
2021
Q4 | $55K | Sell |
|
|||||
|
2021
Q3 | $290K | Buy |
|
|||||
|
2021
Q2 | $242K | Buy |
|
|||||
|
2021
Q1 | $110K | Sell |
|
|||||
|
2020
Q4 | $281K | Buy |
|
|||||
|
2020
Q3 | $204K | Sell |
|
|||||
|
2020
Q2 | $381K | Sell |
|
|||||
|
2020
Q1 | $579K | Buy |
|
|||||
|
2019
Q4 | $372K | Sell |
|
|||||
|
2019
Q3 | $1.23M | Buy |
|
|||||
|
2019
Q2 | $2.23M | Buy |
|
|||||
|
2019
Q1 | $1.81M | Buy |
|
|||||
|
2018
Q4 | $885K | Buy |
|
|||||
|
2018
Q3 | $1.25M | Buy |
|
|||||
|
2018
Q2 | $642K | Sell |
|
|||||
|
2018
Q1 | $10.6M | Buy |
|
|||||
|
2017
Q4 | $142K | Sell |
|
|||||
|
2017
Q3 | $353K | Buy |
|
|||||
|
2017
Q2 | $46K | Sell |
|
|||||
|
2017
Q1 | $369K | Sell |
|
|||||
|
2016
Q4 | $212K | Buy |
|
|||||
|
2016
Q3 | $12K | Sell |
|
|||||
|
2016
Q2 | $336K | Sell |
|
|||||
|
2016
Q1 | $728K | Buy |
|
|||||
|
2015
Q4 | $472K | Sell |
|
|||||
|
2015
Q3 | $531K | Sell |
|
|||||
|
2015
Q2 | $660K | Buy |
|
|||||
|
2015
Q1 | $533K | Sell |
|
|||||
|
2014
Q4 | $785K | Buy |
|
|||||
|
2014
Q3 | $583K | Sell |
|
|||||
|
2014
Q2 | $1M | Sell |
|
|||||
|
2014
Q1 | $956K | Buy |
|
|||||
|
2013
Q4 | $125K | Buy |
|
|||||
|
2013
Q3 | $105K | Sell |
|
|||||
|
2013
Q2 | $167K | Buy |
|